Filing Details

Accession Number:
0001385508-22-000114
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-07-21 16:08:45
Reporting Period:
2022-07-20
Accepted Time:
2022-07-21 16:08:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1385508 Opiant Pharmaceuticals Inc. OPNT Pharmaceutical Preparations (2834) 464744124
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1872022 R. Matthew Ruth C/O Opiant Pharmaceuticals, Inc.
233 Wilshire Blvd, Suite 400
Santa Monica CA 90401
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-07-20 1,084 $10.62 29,916 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
  2. This transaction was executed in multiple trades at prices ranging from $10.34 to $10.75. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.